We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.2B
AUM Growth
-$255M
Cap. Flow
-$342M
Cap. Flow %
-28.37%
Top 10 Hldgs %
51.29%
Holding
4,943
New
709
Increased
1,153
Reduced
1,646
Closed
1,310

Sector Composition

Rank Sector Weight
1 Technology 2.73%
2 Financials 2.53%
3 Healthcare 2.3%
4 Consumer Discretionary 2.11%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFF icon
926
International Flavors & Fragrances
IFF
$21.9B
$102K 0.01%
792
-2,153
-73% -$275K
PFS icon
927
Provident Financial Services
PFS
$3.19B
$102K 0.01%
+4,153
New +$103K
TRHC
928
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$102K 0.01%
2,092
+2,030
+3,274% +$95.1K
BKLN icon
929
Invesco Senior Loan ETF
BKLN
$6.81B
$101K 0.01%
4,438
-5,279
-54% -$119K
CDW icon
930
CDW
CDW
$17B
$101K 0.01%
706
-2,232
-76% -$295K
CLVT icon
931
Clarivate
CLVT
$1.16B
$101K 0.01%
+6,038
New +$102K
DVA icon
932
DaVita
DVA
$11.7B
$101K 0.01%
1,345
-1,611
-54% -$107K
EG icon
933
Everest Group
EG
$14.4B
$101K 0.01%
365
-56
-13% -$14.8K
PEG icon
934
Public Service Enterprise Group
PEG
$37.7B
$101K 0.01%
1,706
-9,853
-85% -$597K
TU icon
935
Telus
TU
$15.3B
$101K 0.01%
5,188
-22,190
-81% -$411K
UNM icon
936
Unum
UNM
$14.3B
$101K 0.01%
3,451
-1,586
-31% -$46.1K
WB icon
937
Weibo
WB
$1.95B
$101K 0.01%
2,182
+1,833
+525% +$85.8K
JNCE
938
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$101K 0.01%
11,559
-4,514
-28% -$24.4K
BCH icon
939
Banco de Chile
BCH
$20.9B
$100K 0.01%
+4,785
New +$116K
COMT icon
940
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.18B
$100K 0.01%
3,045
+2,672
+716% +$85.9K
JBGS
941
JBG SMITH
JBGS
$708M
$100K 0.01%
2,500
-550
-18% -$21.8K
OKE icon
942
Oneok
OKE
$54.5B
$100K 0.01%
1,331
-1,037
-44% -$74.1K
PARA
943
DELISTED
Paramount Global Class B
PARA
$100K 0.01%
2,381
-7,550
-76% -$292K
PBH icon
944
Prestige Consumer Healthcare
PBH
$2.6B
$100K 0.01%
2,458
+801
+48% +$29.9K
SKT icon
945
Tanger
SKT
$4.52B
$100K 0.01%
6,770
-18,871
-74% -$295K
SONY icon
946
Sony
SONY
$138B
$100K 0.01%
7,360
+5,820
+378% +$72.6K
TSN icon
947
Tyson Foods
TSN
$20.4B
$100K 0.01%
1,096
-3,564
-76% -$306K
AWR icon
948
American States Water
AWR
$3.46B
$99K 0.01%
1,144
+1,003
+711% +$88.9K
BSAC icon
949
Banco Santander Chile
BSAC
$16.6B
$99K 0.01%
4,321
+2,640
+157% +$65.6K
CPF icon
950
Central Pacific Financial
CPF
$1B
$99K 0.01%
3,349
+3,197
+2,103% +$93.3K

Similar funds

Tower Research Capital (TRC)'s Q4 2019 Portfolio in Review

As of Q4 2019, Tower Research Capital (TRC) held 4,943 positions worth $1.2B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Tower Research Capital (TRC) withdrew a net $342M in Q4 2019, closing 1,310 positions and reducing 1,646 holdings. Its most notable exit was Wells Fargo, an estimated $7.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 9.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2019 buy was iShares Core S&P 500 ETF: 75,634 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $168M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2019 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $52.3M.
  • Tower Research Capital (TRC) fully exited Wells Fargo in Q4 2019, selling an estimated $7.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 51% of its $1.2B portfolio in Q4 2019.
  • Tower Research Capital (TRC) opened 709 new positions and closed 1,310 in Q4 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.